Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beyond Mitomycin: TGF-beta and wound healing.

M Francesca Cordeiro1

  • 1Department of Pathology, Institute of Ophthalmology and Moorfields Eye Hospital, Bath Street, London EC1V 9EL, UK. m.cordeiro@ucl.ac.uk

Progress in Retinal and Eye Research
|March 22, 2002
PubMed
Summary

Anti-cancer drugs improve glaucoma surgery but cause issues. Targeting transforming growth factor-beta (TGF-beta) offers new ways to control scarring in ocular wound healing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutamesine (SA4503) Protects Retinal Ganglion Cells in an Ocular Hypertension Model of Glaucoma Determined Using Detection of Apoptosing Retinal Cells Technology and RBPMS Cell Marker.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2025
Same author

Low-concentration bimatoprost 0.01% and timolol 0.1% eye gel versus bimatoprost 0.03% and timolol 0.5% eye drops in open-angle glaucoma or ocular hypertension: a phase III randomised study.

The British journal of ophthalmology·2025
Same author

Retinal thinning in epilepsy: A meta-analysis.

Seizure·2025
Same author

Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive rats.

Scientific reports·2025
Same author

Dual lateral flow assay using quantum nanobeads for quantitative detection of BDNF and TNF-α in tears.

Lab on a chip·2025
Same author

Genetic Testing of Patients with Inherited Retinal Diseases in the European Countries: An International Survey by the European Vision Institute.

Ophthalmic research·2024

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Wound Healing Research

Background:

  • Mitomycin and 5-fluorouracil have improved glaucoma surgery outcomes.
  • These anti-scarring agents present emerging challenges.
  • Transforming growth factor-beta (TGF-beta) is key in conjunctival scarring during wound healing.

Purpose of the Study:

  • To review the biology and role of TGF-beta in ocular wound healing.
  • To discuss novel molecular therapies targeting TGF-beta for wound modulation.
  • To explore strategies for modifying TGF-beta activity in surgical repair.

Main Methods:

  • Literature review of studies on anti-scarring agents in glaucoma surgery.
  • Analysis of research on TGF-beta's function in ocular wound repair.
  • Examination of emerging molecular and therapeutic approaches.

Main Results:

  • Established anti-scarring drugs have limitations.
  • TGF-beta significantly drives ocular wound scarring.
  • Targeting TGF-beta presents promising therapeutic avenues.

Conclusions:

  • Modulating TGF-beta offers potential for improved ocular wound healing.
  • New molecular therapies targeting TGF-beta are under development.
  • Further research is needed to refine TGF-beta targeted treatments.

Related Experiment Videos